Zulia Guzmán-Martínez

Zulia Guzmán-Martínez

Auto-generated profile, based on publicly available information

Zulia Guzmán-Martínez

Servicio de Hematología, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2024 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
PCPerla R. Colunga-Pedraza
Perla R. Colunga-Pedraza
HVHéctor A. Vaquera-Alfaro
Héctor A. Vaquera-Alfaro
ZGZulia Guzmán-Martínez
Zulia Guzmán-Martínez
MAMarion Carolina Alemán-Jiménez
Marion Carolina Alemán-Jiménez
AVAntonio Vega-Mateos
Antonio Vega-Mateos
DGDavid Gómez-Almaguer
David Gómez-Almaguer

1 January 2025 in Case Reports in Hematology
Verified
Journal Article
Open access
AMAnahí Morales-Pedraza
Anahí Morales-Pedraza
ZGZulia Guzmán-Martínez
Zulia Guzmán-Martínez
ATAna C. Tejada-Vásquez
Ana C. Tejada-Vásquez
HVHéctor A. Vaquera-Alfaro
Héctor A. Vaquera-Alfaro
SHSilvia E. Haces-Rodríguez
Silvia E. Haces-Rodríguez
PCPerla R. Colunga-Pedraza
Perla R. Colunga-Pedraza
Non‐Hodgkin lymphoma englobes a diverse group of malignant disorders. Although most commonly manifested as lymphadenopathies or solid tumors, some lymphomas can exhibit highly aggressive behavior, such as diffuse large B‐cell lymphoma (DLBCL). This report highlights the case of a 72‐year‐old male from a resource‐limited setting who delayed seeking medical care for two years, relying on alternative medicine for a destructive sternal mass. In low‐ and middle‐income countries (LMICs), healthcare‐seeking decisions are influenced by factors such as poor dimension of symptoms, cultural beliefs, limited access to health care, and reliance on traditional, conventional, and alternative treatment. This case highlights challenges in LMICs in cancer care and the urgent need to address these barriers. This case proposes that efforts should focus on reducing patient intervals and improving cancer outcomes in LMICs.